A new oral HER2-directed breast cancer therapy from Bayer AG, and its companion diagnostic from Thermo Fisher Scientific Inc., have been approved by the U.S. FDA. Hyrnuo (sevabertinib), a reversible ...
Abbott Laboratories made plans to enter the cancer screening market with its reported acquisition of Exact Sciences Corp. The ...
Could GLP-1 receptor agonists (GLP-1RAs), already used in obesity and diabetes, be repurposed as drugs to slow aging? Hong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback